Evidence map›Paper›PMID 11732330›Full record

ArticleProtoplasma2001

Cellular redox state and activating protein-1 are involved in ascorbate effect on calcitriol-induced differentiation.

G López-Lluch, M V Blázquez, R Pérez-Vicente, A Macho, M I Burón, F J Alcaín, E Muñoz, P Navas

Abstract read
PubMed Publisher
In one paragraph

Article in Protoplasma, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

G López-LluchLaboratorio Andaluz de Biología, Universidad Pablo de Olavide, Sevilla, Carretera de Utrera, Km 1.0, 41013 Sevilla, Spain.
M V Blázquez
R Pérez-Vicente
A Macho
M I Burón
F J Alcaín
E Muñoz
P Navas
University of Córdoba · ESUniversidad Pablo de Olavide · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ascorbate has been related to the differentiation of several mesenchymal cells including haematopoietic cells. We have previously demonstrated that ascorbate enhances the activity of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) on monocytic differentiation of HL-60 cells. Here, we show that ascorbate-mediated modification of cellular redox state and AP-1 (activating protein-1) DNA binding during early phases are related to the enhancing effect of ascorbate on differentiation. Ascorbate, but not its fully oxidized form, dehydroascorbate, or an ascorbate analogue with a low rate of oxidation, ascorbate-2-phosphate, enhanced the differentiation induced by 1 alpha,25(OH)2D3, modified cytosolic reactive oxygen species levels and mitochondrial redox potential (delta psi m), and modulated AP-1 DNA binding in HL-60 cells. Ascorbate itself increased AP-1 binding to DNA in noninduced cells, whereas it inhibited AP-1 binding in 1 alpha,25(OH)2D3-induced cells. However, ascorbate increased the mRNA levels of c-jun, junB, and c-fos in 1 alpha,25(OH)2D3-induced cells. Taken together, these results suggest that the enhancing effect of ascorbate on HL-60 differentiation induced by 1 alpha, 25(OH)2D3 is related to its effect on the cellular redox state and the modulation of AP-1 activity.

Indexed as

Ascorbic AcidCalcitriolCell DifferentiationDNAEthanolHL-60 CellsHumansMembrane PotentialsMitochondriaMonocytesOxidation-ReductionProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junReactive Oxygen SpeciesTranscription Factor AP-1Ascorbic AcidCalcitriolDNAEthanolProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junReactive Oxygen SpeciesTranscription Factor AP-1

Identifiers

PMID11732330
OpenAlexW2010272496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.